Transforming growth factor-β1-antisense modulates the expression of hepatocyte growth factor/scatter factor in keloid fibroblast cell culture

Aesthetic Plastic Surgery

Volumn 32, Issue 2, 2008, Pages 346-352

  Naim, R ^a   Naumann, A ^a   Barnes, J ^c   Sauter, A ^b   Hormann, K ^b   Merkel, D ^a   Aust, W ^a   Braun, T ^b   Bloching, M ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Antisense; Fibroblasts; HGF SF; Keloid; Scar; TGF 1

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; INCUBATION TIME; KELOID; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

ADULT; BLOTTING, WESTERN; CICATRIX; DNA, ANTISENSE; FEMALE; FIBROBLASTS; HEPATOCYTE GROWTH FACTOR; HUMANS; KELOID; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; WOUND HEALING;

EID: 40149103283     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-007-9078-6     Document Type: Article

References (48)

1. Medical Data International (1998) U.S. markets for wound management products. Medical Data International, Irvine, CA
2. Hunt TK (1980) Disorders of wound healing. World J Surg 4:271-277
3. Tonnesen MG, Feng X, Clark RA (2000) Angiogenesis in wound healing. J Investig Dermatol Symp Proc 5:40-46
4. Ferguson MW, Whitby DJ, Shah M, Armstrong J, Siebert JW, Longaker MT (1996) Scar formation: The spectral nature of fetal and adult wound repair. Plast Reconstr Surg 97:854-860
5. Koonin AJ (1964) The aetiology of keloids: A review of the literature and a new hypothesis. S Afr Med J 38:913-916
6. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH (1986) Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171
7. Kamamoto F, Paggiaro AO, Rodas A, Herson MR, Mathor MB, Ferreira MC (2003) A wound contraction experimental model for studying keloids and wound-healing modulators. Artif Organs 27:701-705
8. Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E (2000) Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc Natl Acad Sci USA 97:2626-2631
9. Roberts AB, Anzano MA, Lamb LC, Smith JM, Sporn MB (1981) New class of transforming growth factors potentiated by epidermal growth factor: Isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339-5343
10. Anzano MA, Roberts AB, Smith JM, Sporn MB, De Larco JE (1983) Sarcoma growth factor from conditioned medium of virally transformed cells is composed of both type alpha and type beta transforming growth factors. Proc Natl Acad Sci USA 80:6264-6268
11. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN (1995) Transforming growth factor-beta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun 215:386-393
12. Yue J, Mulder KM (2001) Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 91:1-34
13. Chattopadhyay N, Felt HJ, Godbole MM, Brown EM (2004) Transforming growth factor beta receptor family ligands inhibit hepatocyte growth factor synthesis and secretion from astrocytoma cells. Brain Res Mol Brain Res 121:146-150
14. Samuel W, Nagineni CN, Kutty RK, Parks WT, Gordon JS, Prouty SM, Hooks JJ, Wiggert B (2002) Transforming growth factor-beta regulates stearoyl coenzyme A desaturase expression through a SMAD-signaling pathway. J Biol Chem 277:59-66
15. Roberts AB, Wakefield LM (2003) The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci USA 100:8621-8623
16. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802-804
17. Koli K, Saharinen J, Hyytiainen M, Penttinen C, Keski-Oja J (2001) Latency, activation, and binding proteins of TGF-beta. Microsc Res Tech 52:354-362
18. Khalil N (1999) TGF-beta: From latent to active. Microbes Infect 1:1255-1263
19. Gleizes PE, Munger JS, Nunes I, Harpel JG, Mazzieri R, Noguera I, Rifkin DB (1997) TGF-beta latency: Biological significance and mechanisms of activation. Stem Cells 15:190-197
20. Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274:13586-13593
21. Heldin CH, Miyazono K, ten Dijke P (1997) TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471
22. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K (1998) SMAD proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 17:4056-4065
23. Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67:753-791
24. Dai C, Liu Y (2004) Hepatocyte growth factor antagonizes the profibrotic action of TGF-beta1 in mesangial cells by stabilizing SMAD transcriptional corepressor TGIF. J Am Soc Nephrol 15:1402-1412
25. Nakamura T, Nawa K, Ichihara A, Kaise N, Nishino T (1987) Purification and subunit structure of hepatocyte growth factor from rat platelets. FEBS Lett 224:311-316
26. Defacque H, Piquemal D, Basset A, Marti J, Commes T (1999) Transforming growth factor-beta 1 is an autocrine mediator of U937 cell growth arrest and differentiation induced by vitamin D3 and retinoids. J Cell Physiol 178:109-119
27. Zhang X, Yang J, Li Y, Liu Y (2005) Both Sp1 and SMAD participate in mediating TGF-beta 1-induced HGF receptor expression in renal epithelial cells. Am J Physiol Renal Physiol 288:F16-F26
28. Bortz J, Lienert G, Boehnke K (2000) Verteilungsfreie Methoden in der Biostatistik. Springer Verlag, Berlin
29. Krummel TM, Michna BA, Thomas BL, Sporn MB, Nelson JM, Salzberg AM, Cohen IK, Diegelmann RF (1988) Transforming growth factor beta (TGF-beta) induces fibrosis in a fetal wound model. J Pediatr Surg 23:647-652
30. Shah M, Foreman DM, Ferguson MW (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339:213-214
31. Naim R, Sadick H, Bayerl C, Riedel F, Schafer C, Bran G, Hormann K (2005) Hepatocyte growth factor/scatter factor induces VEGF in human external auditory canal cholesteatoma cell culture. Int J Mol Med 15:67-71
32. Ito W, Kanehiro A, Matsumoto K, Hirano A, Ono K, Maruyama H, Kataoka M, Nakamura T, Gelfand EW, Tanimoto M (2005) Hepatocyte growth factor attenuates airway hyperresponsiveness, inflammation, and remodeling. Am J Respir Cell Mol Biol 32:268-280
33. Ono I, Yamashita T, Hida T, Jin HY, Ito Y, Hamada H, Akasaka Y, Ishii T, Jimbow K (2004) Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. J Surg Res 120:47-55
34. Naim R, Shen T, Riedel F, Bran G, Sadick H, Hormann K (2005) Regulation of apoptosis in external auditory canal cholesteatoma by hepatocyte growth factor/scatter factor. ORL J Otorhinolaryngol Relat Spec 67:45-50
35. Messadi DV, Le A, Berg S, Jewett A, Wen Z, Kelly P, Bertolami CN (1999) Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 7:511-517
36. Nagata M, Takenaka H, Shibagaki R, Kishimoto S (1999) Apoptosis and p53 protein expression increase in the process of burn wound healing in guinea-pig skin. Br J Dermatol 140:829-838
37. Akasaka Y, Ishikawa Y, Ono I, Fujita K, Masuda T, Asuwa N, Inuzuka K, Kiguchi H, Ishii T (2000) Enhanced expression of caspase-3 in hypertrophic scars and keloid: Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro. Lab Invest 80:345-357
38. Akasaka Y, Fujita K, Ishikawa Y, Asuwa N, Inuzuka K, Ishihara M, Ito M, Masuda T, Akishima Y, Zhang L, Ito K, Ishii T (2001) Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed flat scars, and dermatofibroma. Wound Repair Regen 9:501-506
39. Sato C, Tsuboi R, Shi CM, Rubin JS, Ogawa H (1995) Comparative study of hepatocyte growth factor/scatter factor and keratinocyte growth factor effects on human keratinocytes. J Invest Dermatol 104:958-963
40. Border WA, Ruoslahti E (1992) Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 90:1-7
41. Shah M, Foreman DM, Ferguson MW (1994) Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J Cell Sci 107(Pt 5):1137-1157
42. Border WA, Ruoslahti E (1990) Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. Cell Differ Dev 32:425-431
43. Wahl SM, Allen JB, Costa GL, Wong HL, Dasch JR (1993) Reversal of acute and chronic synovial inflammation by antitransforming growth factor beta. J Exp Med 177:225-230
44. Beck LS, Deguzman L, Lee WP, Xu Y, McFatridge LA, Amento EP (1991) TGF-beta 1 accelerates wound healing: Reversal of steroid-impaired healing in rats and rabbits. Growth Factors 5:295-304
45. Pierce GF, Mustoe TA, Lingelbach J, Masakowski VR, Gramates P, Deuel TF (1989) Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc Natl Acad Sci USA 86:2229-2233
46. Bernstein EF, Harisiadis L, Salomon G, Norton J, Sollberg S, Uitto J, Glatstein E, Glass J, Talbot T, Russo A (1991) Transforming growth factor-beta improves healing of radiation-impaired wounds. J Invest Dermatol 97:430-434
47. Fujiwara M, Muragaki Y, Ooshima A (2005) Upregulation of transforming growth factor-beta 1 and vascular endothelial growth factor in cultured keloid fibroblasts: Relevance to angiogenic activity. Arch Dermatol Res 297:161-169
48. Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN (2004) Elevated vascular endothelial growth factor in keloids: Relevance to tissue fibrosis. Cells Tissues Organs 176:87-94